1,217
Views
0
CrossRef citations to date
0
Altmetric
Fertility preservation

Expert consensus on fertility preservation in patients with breast cancer occurring during pregnancy

ORCID Icon &
Pages 797-802 | Received 25 May 2022, Accepted 02 Sep 2022, Published online: 14 Sep 2022

References

  • Breast Cancer Expert Committee of National Cancer Quality Control Center. Quality control index for standardized diagnosis and treatment of breast cancer in China (2022 Edition). Chin J Oncol. 2022;44(3):203–208. In Chinese.
  • Breast Surgery Group of Surgery Branch of Chinese Medical Association. Expert consensus on clinical treatment of pregnancy-associated breast cancer (2020 Edition). Chin J Clinicians (Electronic Edition). 2020;14(5):321–325. In Chinese.
  • Amant F, Loibl S, Neven P, et al. Breast cancer in pregnancy. Lancet. 2012;379(9815):570–579.
  • Dalmartello M, Negri E, La Vecchia C, et al. Frequency of pregnancy-associated cancer: a systematic review of population-based studies. Cancers (Basel). 2020;12(6):1356.
  • Amant F, Lefrere H, Borges VF, et al. The definition of pregnancy-associated breast cancer is outdated and should no longer be used. Lancet Oncol. 2021;22(6):753–754.
  • de Haan J, Verheecke M, Van Calsteren K, et al. Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients. Lancet Oncol. 2018;19(3):337–346.
  • Yang WT, Dryden MJ, Gwyn K, et al. Imaging of breast cancer diagnosed and treated with chemotherapy during pregnancy. Radiology. 2006;239(1):52–60.
  • Cordeiro CN, Gemignani ML. Breast cancer in pregnancy: avoiding fetal harm when maternal treatment is necessary. Breast J. 2017;23(2):200–205.
  • Breast Cancer Professional Committee of China Anti-Cancer Association. Chinese anti-cancer association guidelines and standards for diagnosis and treatment of breast cancer (2021 Edition). China Oncol. 2021. 31(10):954–1040. In Chinese.
  • Committee of Diagnosis, Treatment, and Fertility Management of Chinese Young Breast Cancer Patients. Expert consensus on diagnosis, treatment and fertility management of young breast cancer patients. J Natl Cancer Cent. 2021;1(1):23–30. https://doi.org/10.1016/j.jncc.2021.02.001.
  • China Guideline Committee of Clinical Practice and Fertility Preservation for Breast Cancer in Young Women. Chinese consensus guidelines for breast cancer in young women: clinical practices and fertility preservation. Chin J Oncol. 2019;41(7):486–495. In Chinese.
  • Yu HH, Cheung PS, Leung RC, et al. Current management of pregnancy-associated breast cancer. Hong Kong Med J. 2017;23(4):387–394.
  • Peccatori FA, Azim HJ, Orecchia R, et al. Cancer, pregnancy and fertility: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):i160–i170.
  • Gradishar WJ, Anderson BO, Abraham J, et al. Breast cancer, version 3.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2020;18(4):452–478.
  • Blundo C, Giroda M, Fusco N, et al. Early breast cancers during pregnancy treated with breast-conserving surgery in the first trimester of gestation: a feasibility study. Front Oncol. 2021;11(723693):723693.
  • Loibl S, Schmidt A, Gentilini O, et al. Breast cancer diagnosed during pregnancy: adapting recent advances in breast cancer care for pregnant patients. JAMA Oncol. 2015;1(8):1145–1153.
  • Zagouri F, Sergentanis TN, Chrysikos D, et al. Trastuzumab administration during pregnancy: a systematic review and Meta-analysis. Breast Cancer Res Treat. 2013;137(2):349–357.
  • Peccatori FA, Lambertini M, Scarfone G, et al. Biology, staging, and treatment of breast cancer during pregnancy: reassessing the evidences. Cancer Biol Med. 2018;15(1):6–13.
  • Lu D, Ludvigsson JF, Smedby KE, et al. Maternal cancer during pregnancy and risks of stillbirth and infant mortality. J Clin Oncol. 2017;35(14):1522–1529.
  • Amant F, von Minckwitz G, Han SN, et al. Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol. 2013;31(20):2532–2539.
  • Litton JK, Warneke CL, Hahn KM, et al. Case control study of women treated with chemotherapy for breast cancer during pregnancy as compared with nonpregnant patients with breast cancer. Oncologist. 2013;18(4):369–376.
  • Coleman MP, Forman D, Bryant H, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet. 2011;377(9760):127–138.
  • Azim HJ, Santoro L, Pavlidis N, et al. Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies. Eur J Cancer. 2011;47(1):74–83.
  • Gerstl B, Sullivan E, Ives A, et al. Pregnancy outcomes after a breast cancer diagnosis: a systematic review and meta-analysis. Clin Breast Cancer. 2018;18(1):e79–e88.
  • Lambertini M, Goldrat O, Clatot F, et al. Controversies about fertility and pregnancy issues in young breast cancer patients: current state of the art. Curr Opin Oncol. 2017;29(4):243–252.
  • Warner E, Glass K, Foong S, et al. Update on fertility preservation for younger women with breast cancer. CMAJ. 2020;192(35):E1003–E1009.
  • Margulies AL, Selleret L, Zilberman S, et al. Pregnancy after cancer: for whom and when?. Bull Cancer. 2015;102(5):463–469.
  • ASRM. Fertility preservation and reproduction in patients facing gonadotoxic therapies: a committee opinion. Fertil Steril. 2013;100(5):1224–1231.
  • Donnez J, Dolmans MM. Fertility preservation in women. N Engl J Med. 2017;377(17):1657–1665.
  • Kira A, Hentschke MR, Vasconcelos NF, et al. Patients undergoing elective and oncofertility preservation respond similarly to controlled ovarian stimulation for fertility preservation. JBRA Assist Reprod. 2022; 26(3):407–411.
  • Letourneau JM, Wald K, Sinha N, et al. Fertility preservation before breast cancer treatment appears unlikely to affect disease-free survival at a median follow-up of 43 months after fertility-preservation consultation. Cancer. 2020;126(3):487–495.
  • Winship AL, Stringer JM, Liew SH, et al. The importance of DNA repair for maintaining oocyte quality in response to anti-cancer treatments, environmental toxins and maternal ageing. Hum Reprod Update. 2018;24(2):119–134.
  • Ruan X. Chinese Society of Gynecological Endocrinology affiliated to the International Society of Gynecological Endocrinology guideline for ovarian tissue cryopreservation and transplantation. Gynecol Endocrinol. 2018;34(12):1005–1010.
  • Donnez J, Dolmans MM, Demylle D, et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004;364(9443):1405–1410.
  • Dolmans MM, Donnez J, Cacciottola L. Fertility preservation: the challenge of freezing and transplanting ovarian tissue. Trends Mol Med. 2021;27(8):777–791.
  • ASRM. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril. 2019;112(6):1022–1033.
  • Cheng J, Ruan X, Du J, et al. Ovarian tissue cryopreservation in a patient with breast cancer during pregnancy: a case report. J Ovarian Res. 2021;14(1):176.
  • De Vos M, Grynberg M, Ho TM, et al. Perspectives on the development and future of oocyte IVM in clinical practice. J Assist Reprod Genet. 2021;38(6):1265–1280.
  • Liebenthron J, Montag M, Reinsberg J, et al. Overnight ovarian tissue transportation for centralized cryobanking: a feasible option. Reprod Biomed Online. 2019;38(5):740–749.
  • Cacciottola L, Donnez J, Dolmans MM. Ovarian tissue and oocyte cryopreservation prior to iatrogenic premature ovarian insufficiency. Best Pract Res Clin Obstet Gynaecol. 2022;81:119–133.
  • Ruan X, Cheng J, Korell M, et al. Ovarian tissue cryopreservation and transplantation prevents iatrogenic premature ovarian insufficiency: first 10 cases in China. Climacteric. 2020;23(6):574–580.
  • Ruan X, Du J, Lu D, et al. First pregnancy in China after ovarian tissue transplantation to prevent premature ovarian insufficiency. Climacteric. 2021;24(6):624–628.
  • Ruan X, Du J, Lu D, et al. First live birth in China after cryopreserved ovarian tissue transplantation to prevent premature ovarian insufficiency. Climacteric. 2022;25:1–4. Online ahead of print.
  • Dolmans MM, von Wolff M, Poirot C, et al. Transplantation of cryopreserved ovarian tissue in a series of 285 women: a review of five leading European centers. Fertil Steril. 2021;115(5):1102–1115.
  • Arvold ND, Taghian AG, Niemierko A, et al. Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. J Clin Oncol. 2011;29(29):3885–3891.
  • Diaz-Garcia C, Domingo J, Garcia-Velasco JA, et al. Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study. Fertil Steril. 2018;109(3):478–485.e2.
  • Bartelink H, Horiot JC, Poortmans P, et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med. 2001;345(19):1378–1387.
  • Gellert SE, Pors SE, Kristensen SG, et al. Transplantation of frozen-thawed ovarian tissue: an update on worldwide activity published in peer-reviewed papers and on the Danish cohort. J Assist Reprod Genet. 2018;35(4):561–570.
  • Lambertini M, Peccatori FA, Demeestere I, ESMO Guidelines Committee, et al. Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines(dagger). Ann Oncol. 2020;31(12):1664–1678.
  • Munhoz RR, Pereira AA, Sasse AD, et al. Gonadotropin-Releasing hormone agonists for ovarian function preservation in premenopausal women undergoing chemotherapy for early-stage breast cancer: a systematic review and meta-analysis. JAMA Oncol. 2016;2(1):65–73.
  • Lambertini M, Moore H, Leonard R, et al. Gonadotropin-releasing hormone agonists during chemotherapy for preservation of ovarian function and fertility in premenopausal patients with early breast cancer: a systematic review and meta-analysis of individual patient-level data. J Clin Oncol. 2018;36(19):1981–1990.